The Michigan Engineer News Center

Frederick N. Rhines Fellowship Fund established

Dr. Walden C. (BSE Met.E. ’68) and Paula H. Rhines have provided a gift of endowment to establish the Frederick N. Rhines Fellowship Fund. This gift will support graduate students in the Department of Materials Science and Engineering.| Short Read

Dr. Walden C. (BSE Met.E. ’68) and Paula H. Rhines have recently provided a gift of endowment to establish the Frederick N. Rhines Fellowship Fund. Dr. and Mrs. Rhines established this fund in honor of Dr. Rhines’ father, Dr. Frederick N. Rhines (BSE ChE ’29), and will support graduate students in the Department of Materials Science and Engineering. This gift qualifies for the Bicentennial Opportunity Matching Initiative.

Since 1993, Dr. Rhines has served as the CEO and chairman of Mentor Graphics, a leader in worldwide electronic design automation. He is a recognized spokesperson for the semiconductor and electronic design automation industries with over 40 years of experience in this field. His father, Dr. Frederick N. Rhines was an engineering professor at the University of Florida. He founded the Department of Materials Science and received the prestigious 1972-73 Scholar of the Year award by the University of Florida.

Dr. Rhines expressed, “My father and I both graduated from the College of Engineering, with degrees in Chemical/Metallurgical Engineering. We have both been grateful for the high quality education UM provided and the doors it opened for exciting careers built upon a foundation in materials science and engineering. I’m pleased that my wife and I can express our gratitude to the College by funding some of the education of future students.”

Portrait of John Balbach

Contact

John Balbach
Executive Director of Advancement

Michigan Engineering

(734) 763-0893

2002 LEC

Fighting cancer with cancer: 3D cultured cells could drive precision therapy

U-M researchers have devised a process that can grow hundreds of cultured cancer cell masses, called spheroids, from just a few tumor cells derived from a patient. | Medium Read